MedTrace Logo

Implementing a Virtual Tobacco Treatment for Cancer Patients in Community Oncology Practices

NCT03808818 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 306

Last updated 2025-03-18

Study results available
· View outcomes & findings →

Summary

This phase II trial studies how well smoking cessation treatment plans work in tobacco-dependent cancer patients when delivered virtually as part of their cancer care in community oncology practices. Virtual information and counseling sessions may help cancer patients quit smoking.

Conditions

  • Carcinoma In Situ
  • Current Smoker
  • Malignant Neoplasm
  • Primary Neoplasm
  • Recurrent Neoplasm
  • Smoking Cessation

Interventions

OTHER

Behavioral, Psychological or Informational Intervention

Receive information about tobacco cessation

DRUG

Nicotine Replacement

Given NRT patch or lozenge (or both)

OTHER

Quality-of-Life Assessment

Ancillary studies

OTHER

Survey Administration

Ancillary studies

OTHER

Tobacco Cessation Counseling

Receive virtual tobacco cessation counseling

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • ECOG-ACRIN Cancer Research Group

    lead NETWORK

Principal Investigators

  • Elyse Park · ECOG-ACRIN Cancer Research Group

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03808818 on ClinicalTrials.gov